Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	EDWARDS LIFESCIENCES CORPORATION
February 14, 2022	By:	/s/ MICHAEL A. MUSSALLEM
		Michael A. Mussallem Chairman of the Board and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title	Date

/s/ MICHAEL A. MUSSALLEM	Chairman of the Board and Chief Executive Officer	February 14, 2022
Michael A. Mussallem	(Principal Executive Officer)

/s/ SCOTT B. ULLEM	Corporate Vice President, Chief Financial Officer	February 14, 2022
Scott B. Ullem	(Principal Financial Officer)

/s/ ROBERT W.A. SELLERS	Vice President, Corporate Controller	February 14, 2022
Robert W.A. Sellers	(Principal Accounting Officer)

/s/ KIERAN T. GALLAHUE	Director	February 14, 2022
Kieran T. Gallahue

/s/ LESLIE S. HEISZ	Director	February 14, 2022
Leslie S. Heisz

/s/ PAUL A. LAVIOLETTE	Director	February 14, 2022
Paul A. LaViolette

/s/ STEVEN R. LORANGER	Director	February 14, 2022
Steven R. Loranger

/s/ MARTHA H. MARSH	Director	February 14, 2022
Martha H. Marsh

/s/ RAMONA SEQUEIRA	Director	February 14, 2022
Ramona Sequeira

/s/ NICHOLAS J. VALERIANI	Director	February 14, 2022
Nicholas J. Valeriani

Previous: Item 15. Exhibits and Financial Statement Schedules